95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.55%
Revenue growth under 50% of FNV's 77.17%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
42.29%
Gross profit growth at 50-75% of FNV's 79.92%. Martin Whitman would question if cost structure or brand is lagging.
31.40%
EBIT growth 75-90% of FNV's 35.28%. Bill Ackman would push for cost reforms or better product mix to narrow the gap.
31.40%
Operating income growth under 50% of FNV's 200.11%. Michael Burry would be concerned about deeper cost or sales issues.
19.33%
Net income growth under 50% of FNV's 254.09%. Michael Burry would suspect the firm is falling well behind a key competitor.
-73.33%
Negative EPS growth while FNV is at 53.85%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-69.23%
Negative diluted EPS growth while FNV is at 46.15%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.16%
Share reduction more than 1.5x FNV's 0.53%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.51%
Reduced diluted shares while FNV is at 0.57%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
16.30%
Positive OCF growth while FNV is negative. John Neff would see this as a clear operational advantage vs. the competitor.
17.36%
Positive FCF growth while FNV is negative. John Neff would see a strong competitive edge in net cash generation.
78.28%
10Y revenue/share CAGR above 1.5x FNV's 43.91%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
140.24%
5Y revenue/share CAGR above 1.5x FNV's 43.91%. David Dodd would look for consistent product or market expansions fueling outperformance.
48.10%
3Y revenue/share CAGR similar to FNV's 43.91%. Walter Schloss would assume both companies experience comparable short-term cycles.
No Data
No Data available this quarter, please select a different quarter.
252.65%
5Y OCF/share CAGR above 1.5x FNV's 0.57%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
55.50%
3Y OCF/share CAGR above 1.5x FNV's 0.57%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
285.93%
5Y net income/share CAGR above 1.5x FNV's 145.37%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
50.62%
Below 50% of FNV's 145.37%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
440.98%
5Y equity/share CAGR above 1.5x FNV's 13.63%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
60.50%
3Y equity/share CAGR above 1.5x FNV's 13.63%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
47.50%
AR growth well above FNV's 9.72%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
4.08%
Positive asset growth while FNV is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
3.83%
Positive BV/share change while FNV is negative. John Neff sees a clear edge over a competitor losing equity.
-75.82%
We’re deleveraging while FNV stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-14.97%
We cut SG&A while FNV invests at 12.87%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.